The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) – A Report from the Homburg Register for Congenital Aniridia
Klinische Monatsblätter für Augenheilkunde · 01.05.2025 · 242 (05) · 578-583
DOI: 10.1055/a-2194-1580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.05.2025. Verfasst von Fabian Norbert Fries und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg/Saar, Germany. Hauptthemen laut MEDLINE: Aniridia, Glaucoma, Registries, Corneal Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Congenital aniridia is a severe malformation of almost all eye segments. Aniridia-associated keratopathy (AAK) and secondary glaucoma, which occur in more than 50% of affected individuals, are typically progressive and pose a high risk of blindness for patients with congenital aniridia. Our aim was to investigate the effect of glaucoma treatment on AAK in patients of the Homburg Aniridia Center.
Methods
Our retrospective monocentric study included patients who underwent a comprehensive ophthalmological examination at the Homburg Aniridia Center between June 2003 and January 2022.
Results
There were 556 eyes of 286 subjects (20.1 ± 20.1 years; 45.5% males) included. In 307 (55.2%) eyes of 163 subjects (27.5 ± 16.3 years; 43.1% males), glaucoma was present at the time of examination. The mean intraocular pressure in the glaucoma group was 19.0 mmHg (± 8.0), while in the non-glaucoma group, it was 14.1 mmHg (± 3.6) (p < 0.001). In the glaucoma group, 68 patients used antiglaucomatous topical monotherapy, 51 patients used 2 agents, 41 patients used 3 agents, 7 patients used quadruple therapy, and 140 did not use topical therapy (e.g., after pressure-lowering surgery, pain-free end-stage glaucoma, or incompliance). Patients were classified according to the following stages of AAK: Stage 0 (96 eyes [17.2%], no keratopathy), Stage 1 (178 eyes [32.0%]), Stage 2 (107 eyes [19.2%]), Stage 3 (67 eyes [12.0%]), Stage 4 (62 eyes [11.1%]), Stage 5 (45 eyes [8.0%]). The mean stage of AAK was 1.4 (1.2 – 1.5) in the group without eye drops, 1.9 (1.5 – 2.2) in the group with monotherapy, 1.8 (1.5 – 2.1) in the group with 2 drugs, 1.9 (1.5 – 2.2) in the group with 3 drugs, 3.4 (2.3 – 4.6) in the group with 4 drugs, and 3.3 (3.1 – 3.6) after antiglaucomatous surgery. The stage of AAK was significantly positively correlated with the number of pressure-lowering eye drops (p < 0.05) and prior pressure-lowering surgery (p < 0.05). Prostaglandin analogues were not correlated with a higher AAK stage compared to the other drug groups.
Conclusions
At the Homburg Aniridia Center, patients using topical antiglaucomatous quadruple therapy or who had previously undergone antiglaucomatous surgery had by far the highest AAK stage. The different drug groups had no influence on the AAK stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg/Saar, Germany.
- Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.
- Department of Ophthalmology, Semmelweis University, Budapest, Hungary.
- Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping, Sweden.
ORCID-Profile: Fabian Norbert Fries, Berthold Seitz, Barbara Käsmann-Kellner
Zitieren
APA
Fries, F. N., Náray, A., Munteanu, C., Stachon, T., Lagali, N., Seitz, B., Käsmann-Kellner, B., & Szentmáry, N. (2025). The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) – A Report from the Homburg Register for Congenital Aniridia. Klinische Monatsblätter für Augenheilkunde, 242(05), 578-583. https://doi.org/10.1055/a-2194-1580
Vancouver
Fries FN, Náray A, Munteanu C, Stachon T, Lagali N, Seitz B, et al. The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) – A Report from the Homburg Register for Congenital Aniridia. Klinische Monatsblätter für Augenheilkunde. 2025;242(05):578-583. doi:10.1055/a-2194-1580
BibTeX
@article{Fries2025,
author = {Fries, Fabian Norbert and Náray, Annamária and Munteanu, Cristian and Stachon, Tanja and Lagali, Neil and Seitz, Berthold and Käsmann-Kellner, Barbara and Szentmáry, Nóra},
title = {The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) – A Report from the Homburg Register for Congenital Aniridia},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2025},
volume = {242},
number = {05},
pages = {578--583},
doi = {10.1055/a-2194-1580}
}
EUVIMED